Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

BACKGROUND. Up to now, neither the optimal treatment regimen for primary mediastinal large B-cell lymphoma (PMBCL), nor poor/favorable prognostic factors for risk stratification at the disease onset have been found. The prognosis of PMBCL is determined by the depth of metabolic response by the time...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Yana Konstantinovna Mangasarova, R. R. Abdurashidova, A. U. Magomedova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, M. O. Bagova, E. A. Fastova, D. S. Belkina, A. M. Kovrigina, N. G. Gabeeva, D. A. Koroleva, S. K. Kravchenko, Yu. A. Chabaeva, E. E. Zvonkov
Formaat:	Artigo
Taal:	Russo
Gepubliceerd in:	Practical Medicine Publishing House 2024-10-01
Reeks:	Клиническая онкогематология
Onderwerpen:	primary mediastinal (thymic) large b-cell lymphoma da-epoch-r high-dose chemotherapy auto-hsct immune checkpoint inhibitors response-adapted strategy of therapy pregnancy
Online toegang:	https://bloodjournal.ru/index.php/coh/article/view/100
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

Gelijkaardige items